We refer to the letter from Bursa Malaysia Securities Berhad ("Bursa Securities") dated 4 June 2026 regarding the sharp rise in price and increased trading volume of the Company's shares recently.
The Board of Directors of GIIB ("the Board"), after having made due enquiry with the directors, major shareholders, and relevant persons, wishes to provide the following responses to the queries raised by Bursa Securities:
1. Any corporate development relating to the Group's business and affairs that has not been previously announced including those in the stage of negotiation/discussion.
There are no corporate developments relating to the Group's business and affairs, save for the potential investment in a healthcare-related business disclosed in the reply to UMA Query dated 4 May 2026. As of the date of this announcement, the details and terms of the potential investment have yet to be finalised. The Company will make the necessary announcements in compliance with the Bursa Securities Main Market Listing Requirements (LR) should there be any material developments regarding this matter.
2. Any rumour or report concerning the business and affairs of the Group that may account for the trading activity.
The Board is not aware of any specific rumour or report concerning the business and affairs of the Group that may account for the trading activity.
3. Any other possible explanation to account for the trading activity.
Save for the potential investment mentioned in Query 1, the Board is not aware of any other possible explanation to account for the trading activity.
4. Compliance with the Bursa Securities LR, in particular Paragraph 9.03 on immediate disclosure obligations.
The Company confirms that it is in compliance with the Bursa Securities LR, in particular Paragraph 9.03 regarding immediate disclosure obligations.
This announcement is dated 5 June 2026.